Detecting diabetes and impaired glucose tolerance in patients with atherosclerotic peripheral arterial disease

International Angiology

Volumn 31, Issue 2, 2012, Pages 125-128

  Green, F C ^b   Levison, R ^a   Newton, D J ^b   Littleford, R ^b   Stonebridge, P A ^b   Belch, J J F ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Diagnosis; Glucose tolerance test; Peripheral arterial disease

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ASSESSMENT; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PREVALENCE; SCOTLAND;

EID: 84862160442     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. American Diabetes Association. Peripheral arterial disease in people with diabetes. Clin Diab 2004;22:181-9.
2. Leibson CL, Ransom JE, Olson W, Zimmerman BR, O'Fallon WM, Palumbo PJ. Peripheral arterial disease, diabetes, and mortality. Diab Care 2004;12:2843-9. (Pubitemid 39565047)
3. Harris M, Klein R, Wellborn T, Knuiman M. Onset of NIDDM occurs at least 4-7 yrs before clinical diagnosis. Diab Care 1992;15:815-9.
4. Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med 2004;140:689-99.
5. de Courten M, Zimmet P. Screening for non-insulin-dependent diabetes mellitus: where to draw the line? Diab Med 1997;14:95-8.
6. Brand FN, Kannel WB, Evans J, Larson MG, Wolf PA. Glucose intolerance, physical signs of peripheral artery disease, and risk of cardiovascular events: the Framingham Study. Am Heart J 1998;136:762-4.
7. Bartnik M, Rydén L, Malmberg K, Öhrvik J, Pyörälä K, Standi E et al. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart. Heart 2007;93:72-7. (Pubitemid 46094058)
8. Tanvetyanon T, Walkenstein MD, Marra A. Inaccurate glucose determination by fingerstick in a patient with peripheral arterial disease. Ann Intern Med 2002;137:W1.
9. World Health Organisation Consultation, Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1. Diagnosis and classification of diabetes mellitus. Report of a WHO Consultation. Geneva: World Health Organisation; 1999.
10. Gregg EW, Gu Q, Williams D, de Rekeneire N, Cheng YJ, Geiss L et al. Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older. Diab Res Clin Pract 2007;77:485-8. (Pubitemid 47214587)
11. Franse LV, Di Bari M, Shorr RI, Resnick HE, van Eijk JTM, Bauer DC et al., for the Health, Aging, and Body Composition Study Group. Type 2 diabetes in older well-functioning people: who is undiagnosed? Diab Care 2001;24:2065-70. (Pubitemid 33716522)
12. Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia 1995;38:86-96.
13. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008;93:2447-53. (Pubitemid 352008502)